Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control

Published:2021-03-01 Issue:5 Volume:131 Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Lhuillier Claire^ORCID,Rudqvist Nils-Petter^ORCID,Yamazaki Takahiro^ORCID,Zhang Tuo^ORCID,Charpentier Maud^ORCID,Galluzzi Lorenzo^ORCID,Dephoure Noah^ORCID,Clement Cristina C.,Santambrogio Laura^ORCID,Zhou Xi Kathy,Formenti Silvia C.,Demaria Sandra^ORCID

Funder

National Institutes of Health

American Association for Cancer Research

U.S. Department of Defense

Breast Cancer Research Foundation

National Cancer Institute

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/138740/files/pdf

Reference63 articles.

1. Neoantigens in cancer immunotherapy

2. Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

3. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

4. Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

5. An immunogenic personal neoantigen vaccine for patients with melanoma

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A recent perspective on designing tumor vaccines for tumor immunology;International Immunopharmacology;2024-12

2. In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model;Radiotherapy and Oncology;2024-11

3. DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors;British Journal of Cancer;2024-09-13

4. Hypoxia-Targeted Immunotherapy with PD-1 Blockade in Head and Neck Cancer;Cancers;2024-08-29

5. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances;Signal Transduction and Targeted Therapy;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3